Liver function tests are blood tests that measure substances that the liver produces. Doctors can use these results to evaluate the health of a person’s liver. Abnormal results can indicate liver ...

An at-home liver test can check for liver disease or help monitor an ongoing condition by measuring certain proteins, enzymes, and bilirubin in your blood. Taking this test can help shed light on the ...

Noninvasive liver diagnostic devices are transforming the detection and management of liver disease. The leading device-based solutions showcase this innovative technology and offer numerous clinical ...

The following are at-home tests that can help a person monitor their liver health. People need to contact their doctor if they receive a test result indicating they may have reduced liver function. A ...

Liver enzymes are proteins in your liver that speed up chemical reactions. If your liver is damaged, blood tests will show abnormally high levels of these enzymes circulating in your bloodstream.

An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...

Catch liver issues early with a simple Liver Function Test (LFT). Learn how this blood test helps detect liver damage before symptoms appear and who should get tested. The liver is one of the most ...

The intelligent Liver Function Testing (iLFT) platform can improve diagnosis and management of chronic liver disease in a primary care setting, new data show. At the European Association for the Study ...

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...

Yes, it is possible to have a normal liver function test if you have cirrhosis, but this is rare. Cirrhosis is a condition that causes scarring and damage of the liver, which can prevent it from ...

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ: CDXC) today announced results from the study “Combined Metabolic Cofactor Supplementation Reduces Liver Fat in Nonalcoholic Fatty Liver Disease” ...